捷强装备 reported revenue of ¥0.17B for the period ended 2026-06-30, +63.9% year on year. Net income was ¥-0.01B, a -6.7% net margin on a 23.2% gross margin. The largest revenue line is 新材料应用产品 at 53% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.17B | +63.9% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 23.2% | Net margin -6.7% |
| Revenue Q/Q | -29.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 新材料应用产品 | ¥0.09B | 52.5% |
| 核辐射监测设备 | ¥0.07B | 39.7% |
| 其他核生化安全装备及配件和技术服务 | ¥0.01B | 2.9% |
| 其他业务 | ¥0.00B | 2.1% |
| 液压动力系统 | ¥0.00B | 1.8% |
| 生物监测设备 | ¥0.00B | 1.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.13B | 76.8% |
| R&D | ¥0.01B | 6.6% |
| SG&A | ¥0.05B | 27.7% |
| Tax & other | ¥0.00B | 1.4% |
| Item | Amount |
|---|---|
| Total assets | ¥1.29B |
| Total liabilities | ¥0.36B |
| Shareholders' equity | ¥0.93B |
| Equity / assets | 71.9% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 184% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
蒙泰高新 ・ 金春股份 ・ 维康药业 ・ 大叶股份 ・ 迦南智能 ・ 盛德鑫泰 ・ 万胜智能 ・ 龙利得 ・ 狄耐克 ・ 海昌新材 ・ 华业香料 ・ 谱尼测试
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies